Jean Talleyrand, M.D. received a BA in Biology from Brown University and an MD from Boston University School of Medicine. He then specialized in Family and Community Medicine at UCSF and acquired an understanding of Complementary and Alternative Medicine. Dr Talleyrand joined the medical cannabis movement in 2004 as founder of MediCann. He currently serves as Chief Medical Officer of the The Clinical Endocannabinoid System Consortium (CESC).The CESC spearheads research on cannabis products and their clinical efficacy. The CESC currently provides MJ Hybrid Solutions with the latest information and scientific discoveries on medical cannabis.